Skip NavigationSkip to Content

Affinity Measurement of Non-covalent Interactions of the Covalent KRAS G12C GDP Inhibitor MRTX849 to RAS Isoforms Using Surface Plasmon Resonance

  1. Author:
    Alexander,Patrick
    Stephen,Andy
  2. Author Address

    NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA. patrick.alexander@nih.gov.,
    1. Year: 2024
  1. Journal: Methods in Molecular Biology (Clifton, N.J.)
    1. 2797
    2. Pages: 103-114
  2. Type of Article: Article
  1. Abstract:

    Surface plasmon resonance (SPR) is an optical effect at an electron-rich surface that enables affinity measurements of biomolecules in real time. It is label free and versatile, not limited to proteins, nucleic acids, and small molecules. SPR is a widely accepted method to measure not only affinity of molecular interactions but also association and dissociation rates of such interactions. In this chapter, we describe a general method to measure the affinity of a small molecule drug, MRTX849, to GDP bound HRAS, KRAS, and NRAS. © 2024. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

    See More

External Sources

  1. DOI: 10.1007/978-1-0716-3822-4_8
  2. PMID: 38570455

Library Notes

  1. Fiscal Year: FY2023-2024
NCI at FrederickClose Button

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel